CN Stock MarketDetailed Quotes

688136 Kexing Biopharm

Watchlist
  • 19.75
  • +0.73+3.84%
Market Closed Jun 3 15:00 CST
3.93BMarket Cap-23262P/E (TTM)

Kexing Biopharm Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kexing Biopharm Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 27, 2024

Revenue(YoY)

360.66M

+11.79%
EPS(YoY)

0.06

+250.00%
Analyst Rating

Buy

Jun 3, 2024

Kexing Biopharm Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.956B--
--2024/FY-- / 1.493B--
--2023/FY1.259B / 1.569B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.956B--
--2024/FY-- / 1.493B--
--2023/FY1.259B / 1.569B--

Kexing Biopharm Earnings Reports

  • 2023 ANNUAL REPORT

    Apr 26 11:00

  • 2024 First Quarter Report

    Apr 26 11:00

  • 2023 Annual Report Summary

    Apr 26 11:00

  • 2023 Annual Results Forecast Correction Notice

    Feb 23 10:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 3, 2024

    Buy

    • Strong Buy

      25.00%

    • Buy

      75.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg